Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Travera Inc
Eli Lilly and Company
National Cancer Institute (NCI)
Bayer
Memorial Sloan Kettering Cancer Center
Alliance for Clinical Trials in Oncology
Arcus Biosciences, Inc.
Memorial Sloan Kettering Cancer Center
Sotio Biotech Inc.
Eli Lilly and Company
Rondo Therapeutics
UMC Utrecht
BeOne Medicines
ViroMissile, Inc.
AstraZeneca
Tizona Therapeutics, Inc
Essen Biotech
Clasp Therapeutics, Inc.
Brigham and Women's Hospital
Baylor College of Medicine
University of Colorado, Denver
MacroGenics
Institut Bergonié
City of Hope Medical Center
Daiichi Sankyo
University of Nebraska
Adela, Inc
Second Life Therapeutics
Ocellaris Pharma, Inc.
Medical College of Wisconsin
Elephas
Var2 Pharmaceuticals
OncoNano Medicine, Inc.
Mayo Clinic
NeoTX Therapeutics Ltd.
BicycleTx Limited
BicycleTx Limited
Massive Bio, Inc.
UNC Lineberger Comprehensive Cancer Center
Actym Therapeutics, Inc.
Institut Bergonié
Washington University School of Medicine
University of Colorado, Denver
Shanghai Escugen Biotechnology Co., Ltd
Washington University School of Medicine
Västernorrland County Council, Sweden
Palleon Pharmaceuticals, Inc.
Sensei Biotherapeutics, Inc.
Merck Sharp & Dohme LLC